Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 7,933-7,944 of 12,112
Behavioral study icon
CompletedNCT07453355

EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand what helps psychoeducation, a guided learning and support program, stay useful, realistic, and easier to follow over time.

In Atakent
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Ondokuz Mayıs University
Condition
Schizophrenia
Drug study icon
TerminatedNCT03768726

Safety study of flexible Doses Of Oral Ziprasidone in Bipolarity

This study was terminated in the United States. It is testing flexible Doses Of Oral Ziprasidone for Bipolarity.

Multiple locations, including Orange City
BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT01349907

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolarity (P05898)

This study exists to understand how the medication Asenapine holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.

Location not clearly listed
BipolarityOtherFrom 10 Years to 18 Years
Countries
Sponsor
Organon and Co
Condition
Bipolarity
Drug study icon
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This study exists to understand how the medication Pimavanserin holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Phoenix
SchizophreniaOtherOver 18 Years
Countries
United States, Canada, Argentina, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study was terminated in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

Multiple locations, including Birmingham
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT06063382

Extra Time on Brazilian College Level Exam for Students With and Without ADHD

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Porto Alegre
ADHDOtherFrom 16 Years to 40 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
ADHD
Other study type icon
CompletedNCT03768674

Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Oslo
Suicidality, PTSD, ...OtherFrom 18 Years to 60 Years
Countries
Norway
Sponsor
Oslo University Hospital
Condition
Suicidality, PTSD, ...
Behavioral study icon
CompletedNCT02874690

Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Cincinnati
ADHDOtherFrom 8 Years to 21 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.